|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$99,969.12 |
3.22% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$95,259.05 |
3.07% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$91,413.24 |
2.94% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$86,271.21 |
2.78% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$83,188.83 |
2.68% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$82,239.90 |
2.65% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$81,466.89 |
2.62% |
| Waters Corporation |
WAT |
941848103 |
184 |
$78,959.92 |
2.54% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$78,329.43 |
2.52% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$77,741.61 |
2.50% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$76,933.64 |
2.48% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$76,044.40 |
2.45% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$76,133.64 |
2.45% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$73,656.00 |
2.37% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$71,355.40 |
2.30% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$69,810.50 |
2.25% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$69,509.57 |
2.24% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$68,825.70 |
2.22% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$68,806.23 |
2.22% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,533.87 |
2.17% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$67,412.60 |
2.17% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$65,215.58 |
2.10% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$63,769.68 |
2.05% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$61,846.62 |
1.99% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$59,319.00 |
1.91% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$58,496.34 |
1.88% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$58,303.73 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$57,912.12 |
1.86% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$57,146.77 |
1.84% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,518.56 |
1.82% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$56,261.04 |
1.81% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$55,847.31 |
1.80% |
| Steris Plc |
STE |
G8473T100 |
265 |
$55,851.40 |
1.80% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$54,003.30 |
1.74% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$51,825.54 |
1.67% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$50,307.49 |
1.62% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$49,931.65 |
1.61% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$48,192.78 |
1.55% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$47,950.20 |
1.54% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$47,811.16 |
1.54% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$47,463.10 |
1.53% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,602.38 |
1.50% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$46,684.95 |
1.50% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$44,960.40 |
1.45% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,529.82 |
1.43% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$43,458.51 |
1.40% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$40,934.96 |
1.32% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$40,341.00 |
1.30% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$40,148.20 |
1.29% |
| US Dollar |
$USD |
|
12,767 |
$12,766.75 |
0.41% |
| Australian Dollar |
$AUD |
|
601 |
$418.28 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|